Backgrounds/Aims: Because of low incidence rates, there have been few reports on the patterns of and risk factors for recurrence after curative resection of the ampulla of Vater (AoV) cancer. The aim of this study was to characterize patterns of recurrence and to evaluate risk factors affecting survival rates and recurrence after curative resection. Methods: Medical records of 181 patients who had undergone pancreaticoduodenectomy with curative intent for AoV adenocarcinoma between December 1994 and March 2010 at Samsung Medical Center were retrospectively reviewed. Factors influencing on overall survival rate, recurrence rates, and recurrence patterns were analyzed. Results: Lymph node metastases and high preoperative serum carcinoembryonic antigen (CEA) level ＞5 ng/ml were identified as independent factors affecting overall survival (p=0.006, p＜0.001, respectively). Among the 181 patients, 69 developed local or distant recurrence within 3 years after curative resection. Lymph node metastasis, preoperative serum CEA level ＞5 ng/ml, and total bilirubin level ＞1.5 mg/dl were identified as independent prognostic factors of recurrence after curative resection (p=0. 008, p＜0.001, p=0.003, respectively). Conclusions: AoV adenocarcinoma has a better prognosis than other periampullary carcinomas, but still has a high recurrence rate, especially during the first three years after curative radical resection. Therefore, careful follow-up is needed during the first 3 years, especially for the higher risk group. Further study of adjuvant therapy to decrease recurrence after curative resection is now warranted. (Korean J Hepatobiliary Pancreat Surg 2011;15:171-178)
INTRODUCTION
Carcinoma of the ampulla of Vater is a rare disease that accounts for 0.6% of gastrointestinal malignancies and 6% of periampullary cancers. 1, 2 It accounts for 20% of resected periampullary cancers, 3, 4 and has been known to have a better prognosis than pancreatic carcinoma and bile duct cancer. 2, 4 Curative resection is the most effective treatment to date. High curative resection rate more than 80% has been achieved with development of effective diagnoses and surgical methods as well as pre-and post-operative management. 2, 5 The complication rate related to surgery has been reported to be less than 10%. 6, 7 To improve the survival rate, other treatments, such as chemotherapy and radiotherapy, have been used in addition to surgery. Although these treatments have been reported to reduce the recurrence rate of the cancer and to increase the quality of life of the patients, no study reporting a significant improvement in the survival rate has been conducted to date. [8] [9] [10] Recently, local resection or endoscopic resection of the ampulla alone was done for patients at early stages or with a high surgical risk, but the prognosis is a subject of controversy.
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Because the incidence of ampullary cancer is relatively low compared to that of other periampullary cancers, reports on prognosis and recurrence of this disease are only a few. In fact, because of this, studies on recurrence and predictors of recurrence are even rarer. At present the recurrence rate has been reported to be 26-46% after curative resection. Therefore, further studies on recurrence and predictive factors after resection, and on adjuvant treatments for recurrence prevention are now required.
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Fig. 2. Kaplan-Meier disease-free survival curve after curative resection for ampullary adenocarcinoma. and 51.4%, respectively (Fig. 2) . In patients who died of cancer, the median and mean survival durations after recurrence were 6.9 and 10.1 months, respectively (range: Yeo et al. 4 Howe et al. 2 Duffy et al. 22 Qiao et al. 6 Chiche et al. 15 Sierzega et al. 20 Woo et al. 17 Haddad et al. 19 Hatzaras et al. Table 2) .
In a univariate analysis of the predictive factors for survival, the following were determined to be factors associated with the prognosis (Table 3) : serum total bilirubin ＞1.5 mg/dl, CA19-9 ＞35 U/ml, CEA ＞5 ng/ml, tumor invasion depth, lymph node metastasis, and surgical method. In a multivariate analysis of predictive factors for survival, CEA ＞5 ng/dl (p＜0.001) and lymph node metastasis (p=0.006) were statistically significant ( Table   4) .
Results of univariate analysis for predictive factors for disease-free survival were the same as for univariate analysis of the predictive factors for survival (Table 5) . In a multivariate analysis of the predictive factors for disease-free survival, the following were shown to be factors predicting recurrence ( nodes/number of lymph nodes resected or examined). 23 In this study, lymph node metastasis was shown to be an independent prognostic factor related to survival rate.
Furthermore, the lymph node metastasis rate in patients with carcinoma of the ampulla of Vater seems to be associated with the survival rate ( Table 7) . Studies on the correlation of lymph node metastasis with prognosis have been conducted. Falconi et al. 23 reported that the prognosis was good when the number of lymph nodes identified in the lymph node dissection was 16 or more, and that poor prognosis was found as LNR increased.
Bogoevski et al. 24 reported that lymph node micrometastasis was found in patients diagnosed with N0 in the postoperative pathologic examination via immunohistochemical staining, and that the prognoses of the N0 patients with lymph node micrometastasis were similar to those of the N1 patients. Howe et al. 2 and Carter et al. 5 reported that in carcinoma of the ampulla of Vater, the pancreatobiliary type showed poorer prognosis than the intestinal type, and that the cancer type was an independent prognostic factor.
Besides the studies on cancer of the ampulla of Vater, studies on periampullary cancer also reported that the pancreatobiliary type showed poorer prognosis, and that the biological behavior of the cancer was a more important predictive factor than the primary site. 3 Particularly, Carter et al. 5 reported that jaundice was more frequently found in the pancreatobiliary type than in the intestinal type. In this study, the total bilirubin concentration was shown to be an independent predictive factor of the disease-free survival rate. This result is likely to be attributable to the histological features of the primary tumor, but it was not thoroughly investigated in this study. Therefore, a further study of the relationship between tumor histological features and prognosis is required.
In this study, lymph node metastasis, high total bilirubin and high CEA before surgery were independent prognostic factors associated with recurrence. In other studies, lymph node metastasis, 16 venous invasion, 17 perineural invasion, 17 and LNR 23 were associated with recurrence. As shown herein, this study and previous studies had common factors associated with the survival and recurrence rates. This result indicates that the survival rate is strongly associated with the recurrence rate in carcinoma of the ampulla of Vater. In studies on recurrence after curative resection, the recurrence rate during the follow-up period was reported to be 26.8-43.6%. In this study, the recurrence rate during the follow-up period and the five-year disease-free survival rate were reported to be 42.5 and 51.4%, respectively, similar to those in the previous studies. [15] [16] [17] 25 An interesting result of this study was that the blood CEA concentration measured before surgery was an independent factor predicting the survival rate and the disease-free survival rate. In addition to this study, Todoroki et al. 25 reported that CEA and CA19-9 were recurrencepredictive factors in a study conducted on 66 ampullary cancer patients who underwent surgical treatment. In this study, CA19-9 was found to be a factor predicting survival rate, which is consistent with results of studies conducted by Nakao et al. 26 and Dorandeu et al. 27 In this study, CA19-9 showed statistical significance in univariate analysis of the disease-free survival rate, whereas it did not show statistical significance in multivariate analysis (p=0.144). As the blood CEA concentration can be easily measured before surgery, it is likely to be useful for the prediction of prognosis and recurrence. Liver metastases are the most common organ metastases, followed by lung metastasis. [15] [16] [17] 25 The results of this study are consistent with the results of the previous study: local recurrence ＞liver metastasis ＞lung metasta- 30 reported that administration of 5-fluorouracil and Cisplatin into the liver cured the hepatic metastasis that occurred after curative resection, and that a state with no recurrence was maintained during the 30-month follow-up period. A continuous study is required to reduce the high recurrence rate of carcinoma of the ampulla of Vater under conservative treatments.
In conclusion, we found that lymph node metastasis is a powerful prognostic factor as well as a recurrence-predictive factor. Blood CEA, which can be easily measured prior to surgery, can be used as a marker for predicting the survival rate and disease-free survival rate after curative surgery. Further studies are required to investigate the utilization of CA19-9 or total bilirubin as a predictive factor of prognosis and recurrence. Comparing to other periampullary cancers, carcinoma of the ampulla of Vater has a higher survival rate but also a high recurrence rate after curative resection. These results support the necessity of proactive follow-up after surgery. In particular, precautions should be taken within 3 years after surgery. If recurrence is suspected, an evaluation process should be conducted for the possibility of local recurrence or liver or lung metastasis. Furthermore, a study on conservative treatments after surgery is required for better prognosis.
